Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sunshine Biopharma (SBFM) Revenue (2018 - 2025)

Historic Revenue for Sunshine Biopharma (SBFM) over the last 9 years, with Q3 2025 value amounting to $9.4 million.

  • Sunshine Biopharma's Revenue rose 1164.17% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.3 million, marking a year-over-year increase of 1324.13%. This contributed to the annual value of $34.9 million for FY2024, which is 4474.99% up from last year.
  • According to the latest figures from Q3 2025, Sunshine Biopharma's Revenue is $9.4 million, which was up 1164.17% from $9.4 million recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Revenue ranged from a high of $9.6 million in Q4 2024 and a low of $40058.0 during Q1 2021
  • Over the past 5 years, Sunshine Biopharma's median Revenue value was $5.6 million (recorded in 2023), while the average stood at $4.8 million.
  • As far as peak fluctuations go, Sunshine Biopharma's Revenue surged by 452868.37% in 2022, and later soared by 115.19% in 2025.
  • Sunshine Biopharma's Revenue (Quarter) stood at $85118.0 in 2021, then soared by 4528.68% to $3.9 million in 2022, then soared by 94.94% to $7.7 million in 2023, then rose by 24.93% to $9.6 million in 2024, then decreased by 1.85% to $9.4 million in 2025.
  • Its Revenue was $9.4 million in Q3 2025, compared to $9.4 million in Q2 2025 and $8.9 million in Q1 2025.